Last reviewed · How we verify
mupirocin, chlorhexidine, & household cleaning/disinfection
mupirocin, chlorhexidine, & household cleaning/disinfection is a disinfectant Small molecule drug developed by loren g miller. It is currently in Phase 3 development for Skin infections, including impetigo and minor cuts and scrapes, Decolonization of MRSA.
Mupirocin and chlorhexidine work by disrupting bacterial cell membranes, ultimately leading to cell death.
Mupirocin and chlorhexidine work by disrupting bacterial cell membranes, ultimately leading to cell death. Used for Skin infections, including impetigo and minor cuts and scrapes, Decolonization of MRSA.
At a glance
| Generic name | mupirocin, chlorhexidine, & household cleaning/disinfection |
|---|---|
| Sponsor | loren g miller |
| Drug class | disinfectant |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
Mupirocin is a lantibiotic that inhibits bacterial protein synthesis, while chlorhexidine is a disinfectant that binds to and disrupts bacterial cell membranes, ultimately leading to cell death. This action is effective against a broad spectrum of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
Approved indications
- Skin infections, including impetigo and minor cuts and scrapes
- Decolonization of MRSA
Common side effects
- Skin irritation
- Allergic contact dermatitis
Key clinical trials
- A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection (PHASE3)
- Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- mupirocin, chlorhexidine, & household cleaning/disinfection CI brief — competitive landscape report
- mupirocin, chlorhexidine, & household cleaning/disinfection updates RSS · CI watch RSS
- loren g miller portfolio CI
Frequently asked questions about mupirocin, chlorhexidine, & household cleaning/disinfection
What is mupirocin, chlorhexidine, & household cleaning/disinfection?
How does mupirocin, chlorhexidine, & household cleaning/disinfection work?
What is mupirocin, chlorhexidine, & household cleaning/disinfection used for?
Who makes mupirocin, chlorhexidine, & household cleaning/disinfection?
What drug class is mupirocin, chlorhexidine, & household cleaning/disinfection in?
What development phase is mupirocin, chlorhexidine, & household cleaning/disinfection in?
What are the side effects of mupirocin, chlorhexidine, & household cleaning/disinfection?
Related
- Drug class: All disinfectant drugs
- Manufacturer: loren g miller — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Skin infections, including impetigo and minor cuts and scrapes
- Indication: Drugs for Decolonization of MRSA
- Compare: mupirocin, chlorhexidine, & household cleaning/disinfection vs similar drugs
- Pricing: mupirocin, chlorhexidine, & household cleaning/disinfection cost, discount & access